Cita APA

Zhou, Z., Yang, Z., Wang, S., Zhang, L., Luo, J., Feng, Y., . . . Guo, X. (2017). The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy. Acta Pharmacol Sin.

Citación estilo Chicago

Zhou, Zhi-rui, Zhao-zhi Yang, Shao-jia Wang, Li Zhang, Ju-rui Luo, Yan Feng, Xiao-li Yu, Xing-xing Chen, y Xiao-mao Guo. "The Chk1 Inhibitor MK-8776 Increases the Radiosensitivity of Human Triple-negative Breast Cancer By Inhibiting Autophagy." Acta Pharmacol Sin 2017.

Cita MLA

Zhou, Zhi-rui, et al. "The Chk1 Inhibitor MK-8776 Increases the Radiosensitivity of Human Triple-negative Breast Cancer By Inhibiting Autophagy." Acta Pharmacol Sin 2017.